PhD, Biochemistry
University of North Carolina at Chapel Hill, Chapel Hill, NC
BS, Biochemistry
Lehigh University, Bethlehem, PA
Gabrielle Dardis provides strategic thinking and cross-functional leadership to visualize, shape, and operationalize complex solutions. She collaborates with internal and external experts across therapeutic areas and research types, offering comprehensive and forward-thinking medical communications expertise to maximize project and publication impact. In particular, she has extensive experience with HEOR, RWE, and patient-centered research projects in oncology, endocrinology, and neurology and neurodegenerative diseases, and academic research experience in oncology. Prior to joining RTI-HS, Dr. Dardis researched oncogenic crosstalk between epigenetic and inflammatory signaling pathways specific to triple negative breast cancer during her thesis work at the University of North Carolina at Chapel Hill (UNC). She has also researched nonapoptotic cell death pathways in triple negative breast cancer during a laboratory rotation at UNC, metabolic pathway targeting in osteosarcoma cells during internships at the Penn State University Cancer Institute, and joint development in the zebrafish tailfin during her undergraduate career at Lehigh University.